Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;100(2):477-479.
doi: 10.1016/j.kint.2021.05.011. Epub 2021 May 23.

Occurrence of severe COVID-19 in vaccinated transplant patients

Sophie Caillard  1 , Nathalie Chavarot  2 , Dominique Bertrand  3 , Nassim Kamar  4 , Olivier Thaunat  5 , Valerie Moal  6 , Christophe Masset  7 , Marc Hazzan  8 , Philippe Gatault  9 , Antoine Sicard  10 , Jonathan M Chemouny  11 , Jean Philippe Rerolle  12 , Charlotte Colosio  13 , Hélène Francois  14 , Jamal Bamoulid  15 , Nicolas Bouvier  16 , Agnès Duveau  17 , Dany Anglicheau  2 , Gilles Blancho  7 ; French Society of Transplantation
Affiliations

Occurrence of severe COVID-19 in vaccinated transplant patients

Sophie Caillard et al. Kidney Int. 2021 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time from the second vaccine dose to the onset of coronavirus disease 2019 (COVID-19) symptoms in each kidney transplant recipient. Y-axis represents each patient case. In all cases, the second dose was administered at a timepoint from February 8 to April 22, 2021. Green bars indicate patients who received the Moderna vaccine; blue bars indicate patients who received the Pfizer/BioNTech vaccine.
See this image and copyright information in PMC

References

    1. Polack F.P., Thomas S.J., Kitchin N. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–416. - PMC - PubMed
    1. Benotmane I., Gautier-Vargas G., Cognard N. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021;99:1498–1500. - PMC - PubMed
    1. Boyarsky B.J., Werbel W.A., Avery R.K. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786. - PMC - PubMed

Substances